Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
Shen C, Fu C, Suo Y, Li K, Zhang Z, Yang S, Zhang Y, Lin Y, Li Z, Wu Z, Huang S, Chen H, Fan Z, Hu H.
Shen C, et al. Among authors: zhang z, zhang y.
Heliyon. 2023 Jun 3;9(6):e16897. doi: 10.1016/j.heliyon.2023.e16897. eCollection 2023 Jun.
Heliyon. 2023.
PMID: 37346342
Free PMC article.
Retracted.